Home › Smoking and Youth › NCT06582693
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Adult Intervention Subject Inclusion Criteria * Males or females ages ≥18 years in age * Self-identify as a current combustible tobacco user * Have a valid cell phone number Child Intervention Subject Inclusion Criteria * Must be a CHOP patient Adult Intervention Subject Exclusion Criteria * \<18 years in age. * Indicates no combustible tobacco smoking Child Intervention Subject Exclusion Criteria * Not a CHOP patient Adult Control Subject Inclusion Criteria * Males or females ages ≥18 years in age * Self-identify as a current combustible tobacco user * Have a valid cell phone number Child Control Subject Inclusion Criteria * Must be a CHOP patient Adult Control Subject Exclusion Criteria * \<18 years in age. * Indicates no combustible tobacco smoking Child Control Subject Exclusion Criteria * Not a CHOP patient
About the study
The goal of this clinical trial is to compare the reach and effectiveness of the Refer2Quit intervention for increasing tobacco use treatment and quit rates among household members who smoke versus a treatment as usual group. This clinical trial also aims to study household member and pediatric patient characteristics that are associated with reach and effectiveness of Refer2Quit.
What is being tested
- Refer2Quit (other)
Sponsor: Children's Hospital of Philadelphia · Participants: 3,200 · Started: Sep 6, 2024
Contact the study team
- Brian P Jenssen, MD, MSHP · Phone: 267-559-1566
Official record on ClinicalTrials.gov — NCT06582693
Locations in the U.S.
| Pennsylvania | Children's Hospital of Philadelphia, Philadelphia |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.